Hollư, Pavol <br/><br/>
Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.  [electronic resource] 

 -  Blood transfusion = Trasfusione del sangue  Jul 2013 
 - 466-8 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>2385-2070 
<br/><br/><label>Standard No.: </label>10.2450/2012.0077-12  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Factor VIIa--administration & dosage<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Lymphoproliferative Disorders--drug therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Thrombocytopenia--chemically induced